Log in
(Ad)
A brand-new technology - code named "Halo-Fi" - could kill off your overpriced cable company for good... beaming lightning-fast internet to your home for an estimated $7 a month.

This is undoubtedly the beginning of the end for "Big 3" internet providers.

Forward-thinking investors in Halo-Fi are lining up to get rich before January 30th.

Ritter Pharmaceuticals News Headlines (NASDAQ:RTTR)

$0.22
+0.01 (+4.68 %)
(As of 01/21/2020 08:34 AM ET)
Today's Range
$0.21
Now: $0.22
$0.25
50-Day Range
$0.15
MA: $0.19
$0.24
52-Week Range
$0.15
Now: $0.22
$1.35
Volume6.74 million shs
Average Volume5.92 million shs
Market Capitalization$2.27 million
P/E RatioN/A
Dividend YieldN/A
Beta1.01

Headlines

Ritter Pharmaceuticals (NASDAQ RTTR) News Headlines

Source:
DateHeadline
Ritter Pharmaceuticals Inc (NASDAQ:RTTR) Short Interest UpdateRitter Pharmaceuticals Inc (NASDAQ:RTTR) Short Interest Update
www.americanbankingnews.com - January 11 at 2:40 AM
50 Healthcare Stocks Moving In Wednesdays Pre-Market Session50 Healthcare Stocks Moving In Wednesday's Pre-Market Session
www.msn.com - January 8 at 12:51 PM
Ritter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for LactoseRitter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for Lactose
www.bloomberg.com - December 23 at 1:18 PM
Ritter Pharmaceuticals, Inc. Common Stock (RTTR) Institutional HoldingsRitter Pharmaceuticals, Inc. Common Stock (RTTR) Institutional Holdings
www.nasdaq.com - November 21 at 10:20 PM
What Kind Of Investor Owns Most Of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR)?What Kind Of Investor Owns Most Of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR)?
finance.yahoo.com - November 19 at 1:50 PM
Ritter Pharmaceuticals Reports Financial Results...Ritter Pharmaceuticals Reports Financial Results...
www.benzinga.com - November 13 at 10:57 PM
Ritter Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2019 and Provides Business UpdateRitter Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2019 and Provides Business Update
finance.yahoo.com - November 13 at 10:57 PM
Ritter Pharmaceuticals Engages Financial Advisor to Explore Strategic AlternativesRitter Pharmaceuticals Engages Financial Advisor to Explore Strategic Alternatives
finance.yahoo.com - October 7 at 9:39 AM
What Kind Of Share Price Volatility Should You Expect For Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR)?What Kind Of Share Price Volatility Should You Expect For Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR)?
finance.yahoo.com - September 20 at 4:07 PM
Ritter Pharmas RP-G28 flunks late-stage studyRitter Pharma's RP-G28 flunks late-stage study
seekingalpha.com - September 13 at 2:31 PM
MCF, RTTR among premarket losersMCF, RTTR among premarket losers
seekingalpha.com - September 13 at 2:31 PM
Investors Push Ritter Pharma Shares To Record Low Over Failed Lactose Intolerance Drug TrialInvestors Push Ritter Pharma Shares To Record Low Over Failed Lactose Intolerance Drug Trial
www.benzinga.com - September 13 at 2:31 PM
Ritter Pharmaceuticals, Inc. (RTTR)Ritter Pharmaceuticals, Inc. (RTTR)
finance.yahoo.com - September 13 at 2:31 PM
Ritter Pharmaceuticals EPS beats by $0.18Ritter Pharmaceuticals EPS beats by $0.18
seekingalpha.com - August 14 at 9:26 PM
Ritter Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2019 and Provides a Corporate UpdateRitter Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2019 and Provides a Corporate Update
finance.yahoo.com - August 14 at 9:26 PM
Ritter Pharmaceuticals Appoints Esteemed Gastroenterologist Anthony J. Lembo, M.D. to its Medical Advisory BoardRitter Pharmaceuticals Appoints Esteemed Gastroenterologist Anthony J. Lembo, M.D. to its Medical Advisory Board
finance.yahoo.com - August 13 at 12:19 PM
Ritter Pharmaceuticals Provides Highlights from Lactose Intolerance Market Research CallRitter Pharmaceuticals Provides Highlights from Lactose Intolerance Market Research Call
finance.yahoo.com - August 8 at 5:04 PM
Ritter Pharmaceuticals Hosts Conference Call on August 7, 2019 to Highlight Recent Lactose Intolerance Market Research FindingsRitter Pharmaceuticals Hosts Conference Call on August 7, 2019 to Highlight Recent Lactose Intolerance Market Research Findings
finance.yahoo.com - July 31 at 11:59 AM
Did You Manage To Avoid Ritter Pharmaceuticalss (NASDAQ:RTTR) Devastating 93% Share Price Drop?Did You Manage To Avoid Ritter Pharmaceuticals's (NASDAQ:RTTR) Devastating 93% Share Price Drop?
finance.yahoo.com - July 12 at 4:44 PM
Did You Manage To Avoid Ritter Pharmaceuticals's (NASDAQ:RTTR) Devastating 93% Share Price Drop?Did You Manage To Avoid Ritter Pharmaceuticals's (NASDAQ:RTTR) Devastating 93% Share Price Drop?
finance.yahoo.com - July 12 at 4:44 PM
Ritter Pharmaceuticals Regains Compliance with Nasdaq’s Minimum Bid Price RequirementRitter Pharmaceuticals Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
finance.yahoo.com - July 12 at 10:19 AM
Ritter up 6% premarket on advancement of RP-G28Ritter up 6% premarket on advancement of RP-G28
seekingalpha.com - July 2 at 10:55 AM
Ritter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for Lactose IntoleranceRitter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for Lactose Intolerance
finance.yahoo.com - July 2 at 10:55 AM
Ritter Pharmaceuticals Provides Phase 3 Liberatus Clinical Trial and Regulatory UpdateRitter Pharmaceuticals Provides Phase 3 Liberatus Clinical Trial and Regulatory Update
finance.yahoo.com - June 20 at 11:02 AM
Ritter Pharmaceuticals Shares New Market Research Illuminating the Life Challenges of a Lactose Intolerance SuffererRitter Pharmaceuticals Shares New Market Research Illuminating the Life Challenges of a Lactose Intolerance Sufferer
finance.yahoo.com - May 30 at 11:11 AM
Ritter Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2019Ritter Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2019
finance.yahoo.com - May 15 at 11:29 AM
Ritter up 21% on advancement of lactose intolerance candidate RP-G28Ritter up 21% on advancement of lactose intolerance candidate RP-G28
seekingalpha.com - May 7 at 4:29 PM
Ritter Pharmaceuticals Completes Dosing of Last Patient in Pivotal 557-Subject Phase 3 Clinical Trial of RP-G28 in Patients with Lactose IntoleranceRitter Pharmaceuticals Completes Dosing of Last Patient in Pivotal 557-Subject Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance
finance.yahoo.com - May 7 at 11:22 AM
Will Ritter Pharmaceuticals, Inc.s (NASDAQ:RTTR) Earnings Grow Over The Next Few Years?Will Ritter Pharmaceuticals, Inc.'s (NASDAQ:RTTR) Earnings Grow Over The Next Few Years?
finance.yahoo.com - April 8 at 4:24 PM
Will Ritter Pharmaceuticals, Inc.'s (NASDAQ:RTTR) Earnings Grow Over The Next Few Years?Will Ritter Pharmaceuticals, Inc.'s (NASDAQ:RTTR) Earnings Grow Over The Next Few Years?
finance.yahoo.com - April 8 at 4:24 PM
Ritter Pharmaceuticals Reports Year End 2018 Financial Results and Provides Business UpdateRitter Pharmaceuticals Reports Year End 2018 Financial Results and Provides Business Update
finance.yahoo.com - March 29 at 12:20 PM
Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose IntoleranceRitter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance
finance.yahoo.com - March 5 at 9:59 AM
Dr. William Chey Highlights Unmet Medical Need of Lactose Intolerance and Potential for Phase 3 Drug Candidate RP-G28 in Expert Call Hosted by Ritter Pharmaceuticals - GlobeNewswireDr. William Chey Highlights Unmet Medical Need of Lactose Intolerance and Potential for Phase 3 Drug Candidate RP-G28 in Expert Call Hosted by Ritter Pharmaceuticals - GlobeNewswire
globenewswire.com - March 1 at 12:10 PM
Dr. William Chey Highlights Unmet Medical Need of Lactose Intolerance and Potential for Phase 3 Drug Candidate RP-G28 in Expert Call Hosted by Ritter PharmaceuticalsDr. William Chey Highlights Unmet Medical Need of Lactose Intolerance and Potential for Phase 3 Drug Candidate RP-G28 in Expert Call Hosted by Ritter Pharmaceuticals
finance.yahoo.com - February 28 at 11:50 AM
Ritter Pharmaceuticals to Host Expert Call with Dr. William Chey on February 20, 2019Ritter Pharmaceuticals to Host Expert Call with Dr. William Chey on February 20, 2019
finance.yahoo.com - February 12 at 11:38 AM
What Type Of Shareholder Owns Ritter Pharmaceuticals, Inc.’s (NASDAQ:RTTR)?What Type Of Shareholder Owns Ritter Pharmaceuticals, Inc.’s (NASDAQ:RTTR)?
finance.yahoo.com - February 6 at 4:16 PM
Ritter Pharmaceuticals To Present at Noble Capital Markets Fifteenth Annual Investor/Equity Conference on January 28, 2019 - GlobeNewswireRitter Pharmaceuticals To Present at Noble Capital Markets' Fifteenth Annual Investor/Equity Conference on January 28, 2019 - GlobeNewswire
globenewswire.com - January 23 at 4:07 PM
Ritter Pharmaceuticals To Present at Noble Capital Markets’ Fifteenth Annual Investor/Equity Conference on January 28, 2019Ritter Pharmaceuticals To Present at Noble Capital Markets’ Fifteenth Annual Investor/Equity Conference on January 28, 2019
finance.yahoo.com - January 23 at 10:56 AM
This page was last updated on 1/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel